Skip to content

Aging-US Authors

Aging-US.net features press releases on the latest aging research, plus interviews and from the distinguished network of authors who continue to publish their research with Aging-US.

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • Pinterest
  • SoundCloud
  • Reddit
  • Home
  • News

Aging-US Authors

How Cell Cycle Status Affects Aging Cell Response to Senolytic Drugs
Aging News

How Cell Cycle Status Affects Aging Cell Response to Senolytic Drugs

September 23, 2025September 23, 2025

A new research paper was published in Volume 17, Issue 8 of Aging-US on August 7, 2025, titled “Senescent cell heterogeneity and responses to senolytic treatment are related to cell cycle status during senescence induction.”

Read More
Figure 6. Mechanisms proposed in this study. Cellular senescence
Aging News

Cellular Senescence Involves Gene Repression Through p53-p16/RB-E2F-DREAM Complex

June 13, 2023June 13, 2023

PRESS RELEASE: A new research paper was published in Aging’s Volume 15, Issue 10, entitled, “Key elements of cellular senescence involve transcriptional repression of mitotic and DNA repair genes through the p53-p16/RB-E2F-DREAM complex.”

Read More
Figure 1. Geroconversion as a form of growth.
Aging News

Aging | Cellular Senescence: When Growth Stimulation Meets Cell Cycle Arrest

March 2, 2023March 2, 2023

PRESS RELEASE: Aging published a new review paper in Volume 15, Issue 4, entitled, “Cellular senescence: when growth stimulation meets cell cycle arrest.”

Read More
Aging
Aging Latest Issue News

Aging | The Deubiquitylase USP7 is a Novel Cyclin F-Interacting Protein and Regulates Cyclin F Protein Stability

November 21, 2022November 22, 2022

PRESS RELEASE: A new research paper was published in Aging’s Volume 14, Issue 21, entitled, “The deubiquitylase USP7 is a novel cyclin F-interacting protein and regulates cyclin F protein stability.”

Read More
  • X

Copyright © 2023 Impact Journals, LLC

Impact Journals is a registered trademark of Impact Journals, LLC